Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Vivek Subbiah
Jul 12, 2024, 11:08 |
Blog
Vivek Subbiah: How to Spend Way Less Time on Email Every Day
Vivek Subbiah shared a post on X: "How to Spend Way Less Time on Email…
Jul 9, 2024, 13:49 |
Blog
Vivek Subbiah: Johns Hopkins University will provide tuition-free Medical School for most medical students
Vivek Subbiah shared on X: "Beginning in the fall of 2024, Johns Hopkins University will provide…
Jul 5, 2024, 05:40 |
Blog
Vivek Subbiah: Such a delight to discuss some of the oncology updates at ASCO24 with Chadi Nabhan
Vivek Subbiah shared a post by Chadi Nabhan, Medical Director of The University of Chicago Medical…
Jul 3, 2024, 23:31 |
Blog
A few papers to read about Precision oncology and use of AI suggested by Vivek Subbiah
We are presenting articles suggested by Vivek Subbiah: "1. In advanced prostate cancer, deep learning…
Jul 1, 2024, 16:19 |
Insight
Vivek Subbiah: Two back to back futuristic papers in the journal AI In Precision Oncology
Vivek Subbiah shared on LinkedIn: “Thrilled to have the opportunity to mentor some of the…
Jul 1, 2024, 02:16 |
Blog
Chadi Nabhan: A major collaboration BTW Healthcare Unfiltered and Vivek Subbiah
Chadi Nabhan, Medical Director of The University of Chicago Medical Center, shared on X: “Announcing…
Jun 30, 2024, 12:56 |
Blog
Vivek Subbiah: A delight to interview Dr. Kemi Doll
Vivek Subbiah shared on LinkedIn: "It was a delight to interview Dr. Kemi Doll a gynecologic…
Jun 25, 2024, 03:26 |
Blog
Vivek Subbiah: Such a delight to have our paper published in a journal with the highest impact factor
Vivek Subbiah shared on LinkedIn: "2023 Impact factors for all journals are out!!! CA: A Cancer…
Jun 24, 2024, 15:19 |
Insight
Vivek Subbiah: Precision therapy with ALK inhibitor in ALCL
Vivek Subbiah shared on X: . "Precision therapy with anaplastic lymphoma…
Jun 22, 2024, 15:13 |
Drugs
Vivek Subbiah: Another FDA approval to adagrasib plus cetuximab for KRAS G12C-mutated colorectal cancer
Vivek Subbiah shared on LinkedIn: "It's Friday and time for another FDA approval! FDA grants…
1
2
3
4
5
All:
284
Posts:
21 - 30
Matti Aapro is running for the UICC Board of Directors
CityU-AFCR Symposium on Precision Medicine and Digital Medicine
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
Facebook
RSS Feed
Twitter
Linkedin
Youtube